Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Harvey Investment Co. LLC

Harvey Investment Co. LLC lessened its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 0.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,213 shares of the medical instruments supplier’s stock after selling 10 shares during the period. Mettler-Toledo International accounts for about 2.0% of Harvey Investment Co. LLC’s investment portfolio, making the stock its 19th biggest holding. Harvey Investment Co. LLC owned 0.07% of Mettler-Toledo International worth $17,392,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in MTD. State Street Corp boosted its holdings in shares of Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares in the last quarter. Geode Capital Management LLC boosted its stake in Mettler-Toledo International by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares in the last quarter. Barclays PLC increased its position in shares of Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares during the period. JPMorgan Chase & Co. raised its position in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares in the last quarter. Finally, Loomis Sayles & Co. L P raised its holdings in shares of Mettler-Toledo International by 1.8% in the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after purchasing an additional 3,644 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 140 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now owns 6 shares in the company, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on MTD shares. Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Evercore ISI raised shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price objective for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Wells Fargo & Company decreased their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Finally, Wolfe Research started coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Trading Down 0.5 %

Shares of Mettler-Toledo International stock opened at $1,356.78 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,133.46 and a 1-year high of $1,546.93. The firm has a fifty day simple moving average of $1,276.13 and a 200-day simple moving average of $1,343.24. The stock has a market capitalization of $28.63 billion, a price-to-earnings ratio of 36.58, a PEG ratio of 4.83 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.